$GLUC

Glucose Health, Inc.

CIK:0001420108|SEC Filings

CONDENSED STATEMENTS OF OPERATIONS (unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Condensed Statements Of Operations
REVENUE	$ 23,783	$ 2,110	$ 72,940	$ 298,039
COST OF REVENUES
Cost of revenues	790	4,734	15,700	279,258
GROSS PROFIT	22,993	(2,624)	57,240	18,781
OPERATING EXPENSES
Professional fees	13,664	14,701	39,194	33,665
stock based compensation		1,875	906	1,875
General and administrative	4,694	36,356	24,741	45,040
Total Operating Expenses	18,358	52,932	64,841	80,580
INCOME (LOSS) FROM OPERATIONS	4,635	(55,556)	(7,601)	(61,799)
OTHER INCOME (EXPENSE)
Interest income (expense)	(5,720)	(105,263)	(11,512)	(224,564)
Gain on forgiveness of accounts payable	19,854		58,131
Total other income (expense)	14,134	(105,263)	46,619	(224,564)
INCOME (LOSS) BEFORE INCOME TAXES	18,769	(160,819)	39,018	(286,363)
PROVISION FOR (BENEFIT FROM) INCOME TAXES
NET INCOME (LOSS)	$ 18,769	$ (160,819)	$ 39,018	$ (286,363)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING BASIC AND DILUTED	4,148,101	2,876,993	3,737,319	2,614,975
NET INCOME (LOSS) PER SHARE - BASIC AND DILUTED	$ 0.00	$ (0.06)	$ 0.01	$ (0.11)

CONDENSED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
OPERATING ACTIVITIES:
Net income (loss)	$ 39,018	$ (286,363)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of note discount		201,902
Amortization of intangible asset	45
Common stock issued for services	906	1,875
Bad debt expense	3,150
Gain on settlement of accounts payable	(58,131)
Change in assets and liabilities
Increase in accounts receivable	221	(8,592)
Decrease in inventory		1,952
Decrease (increase) in prepaid expenses and other current assets	(531)	(331)
Increase in accounts payable and accrued expenses	1,416	53,641
Total adjustments	(52,924)	250,447
Net cash used in operating activities	(13,906)	(35,916)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes and loans payable	33,500	128,500
Payments on notes and loans payable	(23,500)	(71,000)
Net cash provided by financing activities	10,000	57,500
NET (DECREASE) INCREASE IN CASH	(3,906)	21,584
CASH - BEGINNING OF PERIOD	20,542	2,055
CASH - END OF PERIOD	16,636	23,639
NON-CASH OPERATING AND INVESTING ACTIVITIES:
Beneficial conversion feature		294,722
Conversion of notes payable and accrued interest to common stock	$ 29,291	$ 451

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2017	Dec. 31, 2016
CURRENT ASSETS
Cash	$ 16,636	$ 20,542
Accounts receivable	9,105	11,724
Prepaid expenses	417	639
Total current assets	26,158	32,905
Other Asset
Intellectual assets, net of accumulated amortization of $105 and $60, respectively	195	240
TOTAL ASSETS	26,353	33,145
CURRENT LIABILITIES
Accounts payable and accrued expenses	78,279	138,134
Accrued interest	41,429	38,631
Notes payable, related party	35,000	35,000
Notes payable	10,000	5,000
Convertible notes payable, related party	112,157	112,157
Convertible notes payable	159,220	164,670
Other notes payable	16,500	35,000
Total current liabilities	452,585	528,592
TOTAL LIABILITIES	452,585	528,592
STOCKHOLDERS' DEFICIT
Preferred stock, no par value, 1,000 shares authorized, 1,000 shares issued and outstanding as of September 30, 2017 and December 31, 2016	113,200	113,200
Common stock, $0.001 par value, 200,000,000 shares authorized, 4,515,810 and 3,312,273 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively	4,516	3,312
Additional paid in capital	5,716,949	5,687,956
Stock subscription	23,000	23,000
Accumulated other comprehensive loss	(75,278)	(75,278)
Accumulated deficit	(6,208,619)	(6,247,637)
Total stockholders' deficit	(426,232)	(495,447)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 26,353	$ 33,145